<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="multinma">
<title>Example: Plaque psoriasis HTA report • multinma</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png">
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png">
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.2.2/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.2.2/bootstrap.bundle.min.js"></script><link href="../deps/Source_Sans_Pro-0.4.7/font.css" rel="stylesheet">
<!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><link href="../extra.css" rel="stylesheet">
<meta property="og:title" content="Example: Plaque psoriasis HTA report">
<meta property="og:description" content="multinma">
<meta property="og:image" content="https://dmphillippo.github.io/multinma/logo.svg">
<meta name="robots" content="noindex">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">multinma</a>

    <small class="nav-text text-danger me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="In-development version">0.5.1.9001</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="active nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/vignette_overview.html">Overview of Examples</a>
    <div class="dropdown-divider"></div>
    <h6 class="dropdown-header" data-toc-skip>Examples</h6>
    <a class="dropdown-item" href="../articles/example_atrial_fibrillation.html">Example: Atrial fibrillation</a>
    <a class="dropdown-item" href="../articles/example_bcg_vaccine.html">Example: BCG vaccine for tuberculosis</a>
    <a class="dropdown-item" href="../articles/example_blocker.html">Example: Beta blockers</a>
    <a class="dropdown-item" href="../articles/example_diabetes.html">Example: Diabetes</a>
    <a class="dropdown-item" href="../articles/example_dietary_fat.html">Example: Dietary fat</a>
    <a class="dropdown-item" href="../articles/example_hta_psoriasis.html">Example: Plaque psoriasis HTA report</a>
    <a class="dropdown-item" href="../articles/example_ndmm.html">Example: Newly diagnosed multiple myeloma</a>
    <a class="dropdown-item" href="../articles/example_parkinsons.html">Example: Parkinson's disease</a>
    <a class="dropdown-item" href="../articles/example_plaque_psoriasis.html">Example: Plaque psoriasis ML-NMR</a>
    <a class="dropdown-item" href="../articles/example_smoking.html">Example: Smoking cessation</a>
    <a class="dropdown-item" href="../articles/example_statins.html">Example: Statins for cholesterol lowering</a>
    <a class="dropdown-item" href="../articles/example_thrombolytics.html">Example: Thrombolytic treatments</a>
    <a class="dropdown-item" href="../articles/example_transfusion.html">Example: White blood cell transfusion</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/dmphillippo/multinma/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.svg" class="logo" alt=""><h1>Example: Plaque psoriasis HTA report</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/dmphillippo/multinma/blob/HEAD/vignettes/example_hta_psoriasis.Rmd" class="external-link"><code>vignettes/example_hta_psoriasis.Rmd</code></a></small>
      <div class="d-none name"><code>example_hta_psoriasis.Rmd</code></div>
    </div>

    
    
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://dmphillippo.github.io/multinma/">multinma</a></span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/options.html" class="external-link">options</a></span><span class="op">(</span>mc.cores <span class="op">=</span> <span class="fu">parallel</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/r/parallel/detectCores.html" class="external-link">detectCores</a></span><span class="op">(</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">#&gt; For execution on a local, multicore CPU with excess RAM we recommend calling</span></span>
<span><span class="co">#&gt; options(mc.cores = parallel::detectCores())</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; Attaching package: 'multinma'</span></span>
<span><span class="co">#&gt; The following objects are masked from 'package:stats':</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;     dgamma, pgamma, qgamma</span></span></code></pre>
<p>This vignette describes the analysis of treatments for
moderate-to-severe plaque psoriasis from an HTA report <span class="citation">(<a href="#ref-Woolacott2006" role="doc-biblioref">Woolacott et al. 2006</a>)</span>, replicating the
analysis in NICE Technical Support Document 2 <span class="citation">(<a href="#ref-TSD2" role="doc-biblioref">Dias et al. 2011</a>)</span>. The
data are available in this package as <code>hta_psoriasis</code>:</p>
<div class="sourceCode" id="cb3"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">hta_psoriasis</span><span class="op">)</span></span>
<span><span class="co">#&gt;   studyn   studyc year trtn             trtc sample_size PASI50 PASI75 PASI90</span></span>
<span><span class="co">#&gt; 1      1  Elewski 2004    1  Supportive care         193     12      5      1</span></span>
<span><span class="co">#&gt; 2      1  Elewski 2004    2 Etanercept 25 mg         196     59     46     21</span></span>
<span><span class="co">#&gt; 3      1  Elewski 2004    3 Etanercept 50 mg         194     54     56     40</span></span>
<span><span class="co">#&gt; 4      2 Gottlieb 2003    1  Supportive care          55      5      1      0</span></span>
<span><span class="co">#&gt; 5      2 Gottlieb 2003    2 Etanercept 25 mg          57     23     11      6</span></span>
<span><span class="co">#&gt; 6      3  Lebwohl 2003    1  Supportive care         122     13      5      1</span></span></code></pre></div>
<p>Outcomes are ordered multinomial success/failure to achieve 50%, 75%,
or 90% reduction in symptoms on the Psoriasis Area and Severity Index
(PASI) scale. Some studies report ordered outcomes at all three
cutpoints, others only one or two:</p>
<div class="sourceCode" id="cb4"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu">dplyr</span><span class="fu">::</span><span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">hta_psoriasis</span>, <span class="va">studyc</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"Elewski"</span>, <span class="st">"Gordon"</span>, <span class="st">"ACD2058g"</span>, <span class="st">"Altmeyer"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   studyn   studyc year trtn             trtc sample_size PASI50 PASI75 PASI90</span></span>
<span><span class="co">#&gt; 1      1  Elewski 2004    1  Supportive care         193     12      5      1</span></span>
<span><span class="co">#&gt; 2      1  Elewski 2004    2 Etanercept 25 mg         196     59     46     21</span></span>
<span><span class="co">#&gt; 3      1  Elewski 2004    3 Etanercept 50 mg         194     54     56     40</span></span>
<span><span class="co">#&gt; 4      5   Gordon 2003    1  Supportive care         187     18      8     NA</span></span>
<span><span class="co">#&gt; 5      5   Gordon 2003    4       Efalizumab         369    118     98     NA</span></span>
<span><span class="co">#&gt; 6      6 ACD2058g 2004    1  Supportive care         170     25     NA     NA</span></span>
<span><span class="co">#&gt; 7      6 ACD2058g 2004    4       Efalizumab         162     99     NA     NA</span></span>
<span><span class="co">#&gt; 8     10 Altmeyer 1994    1  Supportive care          51     NA      1     NA</span></span>
<span><span class="co">#&gt; 9     10 Altmeyer 1994    6         Fumaderm          49     NA     12     NA</span></span></code></pre></div>
<p>Here, the outcome counts are given as “exclusive” counts. That is,
for a study reporting all outcomes (e.g. Elewski), the counts represent
the categories 50 &lt; PASI &lt; 75, 75 &lt; PASI &lt; 90, and 90 &lt;
PASI &lt; 100, and the corresponding columns are named by the lower end
of the interval. Missing values are used where studies only report a
subset of the outcomes. For a study reporting only two outcomes, say
PASI50 and PASI75 as in Gordon, the counts represent the categories 50
&lt; PASI &lt; 75 and 75 &lt; PASI &lt; 100. For a study reporting only
one outcome, say PASI70 as in Altmeyer, the count represents 70 &lt;
PASI &lt; 100. We also need the count for the lowest category (i.e. no
higher outcomes achieved), which is equal to the sample size minus the
counts in the other observed categories.</p>
<div class="section level2">
<h2 id="setting-up-the-network">Setting up the network<a class="anchor" aria-label="anchor" href="#setting-up-the-network"></a>
</h2>
<p>We begin by setting up the network. We have arm-level ordered
multinomial count data, so we use the function
<code><a href="../reference/set_agd_arm.html">set_agd_arm()</a></code>. The function <code><a href="../reference/multi.html">multi()</a></code> helps us
to specify the ordered outcomes correctly.</p>
<div class="sourceCode" id="cb5"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pso_net</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/set_agd_arm.html">set_agd_arm</a></span><span class="op">(</span><span class="va">hta_psoriasis</span>, </span>
<span>                       study <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/paste.html" class="external-link">paste</a></span><span class="op">(</span><span class="va">studyc</span>, <span class="va">year</span><span class="op">)</span>, </span>
<span>                       trt <span class="op">=</span> <span class="va">trtc</span>, </span>
<span>                       r <span class="op">=</span> <span class="fu"><a href="../reference/multi.html">multi</a></span><span class="op">(</span>r0 <span class="op">=</span> <span class="va">sample_size</span> <span class="op">-</span> <span class="fu"><a href="https://rdrr.io/r/base/colSums.html" class="external-link">rowSums</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/cbind.html" class="external-link">cbind</a></span><span class="op">(</span><span class="va">PASI50</span>, <span class="va">PASI75</span>, <span class="va">PASI90</span><span class="op">)</span>, na.rm <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span>, </span>
<span>                                 <span class="va">PASI50</span>, <span class="va">PASI75</span>, <span class="va">PASI90</span>,</span>
<span>                                 inclusive <span class="op">=</span> <span class="cn">FALSE</span>, </span>
<span>                                 type <span class="op">=</span> <span class="st">"ordered"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="va">pso_net</span></span>
<span><span class="co">#&gt; A network with 16 AgD studies (arm-based).</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; <span style="color: #555555;">-------------------------------------------------------</span> <span style="font-weight: bold;">AgD studies (arm-based)</span> <span style="color: #555555;">----</span> </span></span>
<span><span class="co">#&gt;  Study         Treatment arms                                          </span></span>
<span><span class="co">#&gt;  ACD2058g 2004 2: Supportive care | Efalizumab                         </span></span>
<span><span class="co">#&gt;  ACD2600g 2004 2: Supportive care | Efalizumab                         </span></span>
<span><span class="co">#&gt;  Altmeyer 1994 2: Supportive care | Fumaderm                           </span></span>
<span><span class="co">#&gt;  Chaudari 2001 2: Supportive care | Infliximab                         </span></span>
<span><span class="co">#&gt;  Elewski 2004  3: Supportive care | Etanercept 25 mg | Etanercept 50 mg</span></span>
<span><span class="co">#&gt;  Ellis 1991    3: Supportive care | Ciclosporin | Ciclosporin          </span></span>
<span><span class="co">#&gt;  Gordon 2003   2: Supportive care | Efalizumab                         </span></span>
<span><span class="co">#&gt;  Gottlieb 2003 2: Supportive care | Etanercept 25 mg                   </span></span>
<span><span class="co">#&gt;  Gottlieb 2004 3: Supportive care | Infliximab | Infliximab            </span></span>
<span><span class="co">#&gt;  Guenther 1991 2: Supportive care | Ciclosporin                        </span></span>
<span><span class="co">#&gt; <span style="color: #555555;"> ... plus 6 more studies</span></span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;  Outcome type: ordered (4 categories)</span></span>
<span><span class="co">#&gt; <span style="color: #555555;">------------------------------------------------------------------------------------</span></span></span>
<span><span class="co">#&gt; Total number of treatments: 8</span></span>
<span><span class="co">#&gt; Total number of studies: 16</span></span>
<span><span class="co">#&gt; Reference treatment is: Supportive care</span></span>
<span><span class="co">#&gt; Network is <span style="color: #00BB00;">connected</span></span></span></code></pre></div>
<p>Plot the network structure.</p>
<div class="sourceCode" id="cb6"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pso_net</span>, weight_edges <span class="op">=</span> <span class="cn">TRUE</span>, weight_nodes <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span> <span class="op">+</span> </span>
<span>  <span class="co"># Nudge the legend over</span></span>
<span>  <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/theme.html" class="external-link">theme</a></span><span class="op">(</span>legend.box.spacing <span class="op">=</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/r/grid/unit.html" class="external-link">unit</a></span><span class="op">(</span><span class="fl">0.75</span>, <span class="st">"in"</span><span class="op">)</span>,</span>
<span>                 plot.margin <span class="op">=</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/element.html" class="external-link">margin</a></span><span class="op">(</span><span class="fl">0.1</span>, <span class="fl">0</span>, <span class="fl">0.1</span>, <span class="fl">0.75</span>, <span class="st">"in"</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/hta_psoriasis_network_plot-1.png" width="700" style="display: block; margin: auto;"></p>
</div>
<div class="section level2">
<h2 id="meta-analysis-models">Meta-analysis models<a class="anchor" aria-label="anchor" href="#meta-analysis-models"></a>
</h2>
<p>We fit both fixed effect (FE) and random effects (RE) models.</p>
<div class="section level3">
<h3 id="fixed-effect-meta-analysis">Fixed effect meta-analysis<a class="anchor" aria-label="anchor" href="#fixed-effect-meta-analysis"></a>
</h3>
<p>First, we fit a fixed effect model using the <code><a href="../reference/nma.html">nma()</a></code>
function with <code>trt_effects = "fixed"</code>, using a probit link
function <code>link = "probit"</code>. We use <span class="math inline">\(\mathrm{N}(0, 10^2)\)</span> prior distributions
for the treatment effects <span class="math inline">\(d_k\)</span>, and
<span class="math inline">\(\mathrm{N}(0, 100^2)\)</span> prior
distributions for the study-specific intercepts <span class="math inline">\(\mu_j\)</span>. We can examine the range of
parameter values implied by these prior distributions with the
<code><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary()</a></code> method:</p>
<div class="sourceCode" id="cb7"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">10</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; A Normal prior distribution: location = 0, scale = 10.</span></span>
<span><span class="co">#&gt; 50% of the prior density lies between -6.74 and 6.74.</span></span>
<span><span class="co">#&gt; 95% of the prior density lies between -19.6 and 19.6.</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">100</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; A Normal prior distribution: location = 0, scale = 100.</span></span>
<span><span class="co">#&gt; 50% of the prior density lies between -67.45 and 67.45.</span></span>
<span><span class="co">#&gt; 95% of the prior density lies between -196 and 196.</span></span></code></pre></div>
<p>We also need to specify prior distributions for the latent cutpoints
<span class="math inline">\(c_\textrm{PASI75}\)</span> and <span class="math inline">\(c_\textrm{PASI90}\)</span> on the underlying scale
- here the PASI standardised mean difference due to the probit link (the
cutpoint <span class="math inline">\(c_\textrm{PASI50}=0\)</span>). To
make these easier to reason about, we actually specify priors on the
<em>differences</em> between adjacent cutpoints, e.g. <span class="math inline">\(c_\textrm{PASI90} - c_\textrm{PASI75}\)</span> and
<span class="math inline">\(c_\textrm{PASI75} -
c_\textrm{PASI50}\)</span>. These can be given any positive-valued prior
distribution, and Stan will automatically impose the necessary ordering
constraints behind the scenes. We choose to give these implicit flat
priors <code><a href="../reference/priors.html">flat()</a></code>. </p>
<p>The model is fitted using the <code><a href="../reference/nma.html">nma()</a></code> function.</p>
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pso_fit_FE</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/nma.html">nma</a></span><span class="op">(</span><span class="va">pso_net</span>, </span>
<span>                  trt_effects <span class="op">=</span> <span class="st">"fixed"</span>,</span>
<span>                  link <span class="op">=</span> <span class="st">"probit"</span>,</span>
<span>                  prior_intercept <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">100</span><span class="op">)</span>,</span>
<span>                  prior_trt <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">10</span><span class="op">)</span>,</span>
<span>                  prior_aux <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">flat</a></span><span class="op">(</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Note: Setting "Supportive care" as the network reference treatment.</span></span></code></pre></div>
<p>Basic parameter summaries are given by the <code><a href="https://rdrr.io/r/base/print.html" class="external-link">print()</a></code>
method:</p>
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pso_fit_FE</span></span>
<span><span class="co">#&gt; A fixed effects NMA with a ordered likelihood (probit link).</span></span>
<span><span class="co">#&gt; Inference for Stan model: ordered_multinomial.</span></span>
<span><span class="co">#&gt; 4 chains, each with iter=2000; warmup=1000; thin=1; </span></span>
<span><span class="co">#&gt; post-warmup draws per chain=1000, total post-warmup draws=4000.</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;                         mean se_mean   sd     2.5%      25%      50%      75%    97.5% n_eff</span></span>
<span><span class="co">#&gt; d[Ciclosporin]          1.92    0.01 0.34     1.28     1.68     1.90     2.14     2.64  1627</span></span>
<span><span class="co">#&gt; d[Efalizumab]           1.19    0.00 0.06     1.08     1.15     1.19     1.23     1.30  2127</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]     1.51    0.00 0.10     1.32     1.45     1.51     1.57     1.70  2232</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]     1.92    0.00 0.10     1.72     1.86     1.92     1.99     2.11  2119</span></span>
<span><span class="co">#&gt; d[Fumaderm]             1.50    0.01 0.49     0.62     1.16     1.46     1.79     2.52  2554</span></span>
<span><span class="co">#&gt; d[Infliximab]           2.33    0.01 0.26     1.85     2.15     2.32     2.51     2.86  2596</span></span>
<span><span class="co">#&gt; d[Methotrexate]         1.61    0.01 0.45     0.74     1.31     1.60     1.90     2.53  1926</span></span>
<span><span class="co">#&gt; lp__                -3405.08    0.08 3.57 -3412.88 -3407.32 -3404.80 -3402.43 -3399.20  1765</span></span>
<span><span class="co">#&gt; cc[PASI50]              0.00     NaN 0.00     0.00     0.00     0.00     0.00     0.00   NaN</span></span>
<span><span class="co">#&gt; cc[PASI75]              0.76    0.00 0.03     0.70     0.74     0.76     0.78     0.82  5825</span></span>
<span><span class="co">#&gt; cc[PASI90]              1.57    0.00 0.05     1.46     1.53     1.57     1.60     1.67  6099</span></span>
<span><span class="co">#&gt;                     Rhat</span></span>
<span><span class="co">#&gt; d[Ciclosporin]         1</span></span>
<span><span class="co">#&gt; d[Efalizumab]          1</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]    1</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]    1</span></span>
<span><span class="co">#&gt; d[Fumaderm]            1</span></span>
<span><span class="co">#&gt; d[Infliximab]          1</span></span>
<span><span class="co">#&gt; d[Methotrexate]        1</span></span>
<span><span class="co">#&gt; lp__                   1</span></span>
<span><span class="co">#&gt; cc[PASI50]           NaN</span></span>
<span><span class="co">#&gt; cc[PASI75]             1</span></span>
<span><span class="co">#&gt; cc[PASI90]             1</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; Samples were drawn using NUTS(diag_e) at Wed Aug 30 10:58:47 2023.</span></span>
<span><span class="co">#&gt; For each parameter, n_eff is a crude measure of effective sample size,</span></span>
<span><span class="co">#&gt; and Rhat is the potential scale reduction factor on split chains (at </span></span>
<span><span class="co">#&gt; convergence, Rhat=1).</span></span></code></pre></div>
<blockquote>
<p><strong>Note:</strong> the treatment effects are the <em>opposite
sign</em> to those in TSD 2 <span class="citation">(<a href="#ref-TSD2" role="doc-biblioref">Dias et al. 2011</a>)</span>. This is because we
parameterise the linear predictor as <span class="math inline">\(\mu_j +
d_k + c_m\)</span>, rather than <span class="math inline">\(\mu_j + d_k
- c_m\)</span>. The interpretation here thus follows that of a standard
binomial probit (or logit) regression; SMDs (or log ORs) greater than
zero mean that the treatment increases the probability of an event
compared to the comparator (and less than zero mean a reduction in
probability). Here higher outcomes are positive, and all of the active
treatments are estimated to increase the response (i.e. a greater
reduction) on the PASI scale compared to the network reference
(supportive care).</p>
</blockquote>
<p>By default, summaries of the study-specific intercepts <span class="math inline">\(\mu_j\)</span> are hidden, but could be examined
by changing the <code>pars</code> argument:</p>
<div class="sourceCode" id="cb10"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Not run</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/print.html" class="external-link">print</a></span><span class="op">(</span><span class="va">pso_fit_FE</span>, pars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"d"</span>, <span class="st">"mu"</span>, <span class="st">"cc"</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<p>The prior and posterior distributions can be compared visually using
the <code><a href="../reference/plot_prior_posterior.html">plot_prior_posterior()</a></code> function:</p>
<div class="sourceCode" id="cb11"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/plot_prior_posterior.html">plot_prior_posterior</a></span><span class="op">(</span><span class="va">pso_fit_FE</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_FE_pp_plot-1.png" width="700" style="display: block; margin: auto;"></p>
<p>Focusing specifically on the cutpoints we see that these are highly
identified by the data, which is why the implicit flat priors work for
these parameters.</p>
<div class="sourceCode" id="cb12"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/plot_prior_posterior.html">plot_prior_posterior</a></span><span class="op">(</span><span class="va">pso_fit_FE</span>, prior <span class="op">=</span> <span class="st">"aux"</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_FE_pp_cutpoint_plot-1.png" width="700" style="display: block; margin: auto;"></p>
</div>
<div class="section level3">
<h3 id="random-effects-meta-analysis">Random effects meta-analysis<a class="anchor" aria-label="anchor" href="#random-effects-meta-analysis"></a>
</h3>
<p>We now fit a random effects model using the <code><a href="../reference/nma.html">nma()</a></code>
function with <code>trt_effects = "random"</code>. Again, we use <span class="math inline">\(\mathrm{N}(0, 10^2)\)</span> prior distributions
for the treatment effects <span class="math inline">\(d_k\)</span>,
<span class="math inline">\(\mathrm{N}(0, 100^2)\)</span> prior
distributions for the study-specific intercepts <span class="math inline">\(\mu_j\)</span>, implicit flat prior distributions
for the latent cutpoints, and we additionally use a <span class="math inline">\(\textrm{half-N}(2.5^2)\)</span> prior for the
heterogeneity standard deviation <span class="math inline">\(\tau\)</span>. We can examine the range of
parameter values implied by these prior distributions with the
<code><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary()</a></code> method:</p>
<div class="sourceCode" id="cb13"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">10</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; A Normal prior distribution: location = 0, scale = 10.</span></span>
<span><span class="co">#&gt; 50% of the prior density lies between -6.74 and 6.74.</span></span>
<span><span class="co">#&gt; 95% of the prior density lies between -19.6 and 19.6.</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">100</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; A Normal prior distribution: location = 0, scale = 100.</span></span>
<span><span class="co">#&gt; 50% of the prior density lies between -67.45 and 67.45.</span></span>
<span><span class="co">#&gt; 95% of the prior density lies between -196 and 196.</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="fu"><a href="../reference/priors.html">half_normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">2.5</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; A half-Normal prior distribution: location = 0, scale = 2.5.</span></span>
<span><span class="co">#&gt; 50% of the prior density lies between 0 and 1.69.</span></span>
<span><span class="co">#&gt; 95% of the prior density lies between 0 and 4.9.</span></span></code></pre></div>
<p>Fitting the RE model</p>
<div class="sourceCode" id="cb14"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pso_fit_RE</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/nma.html">nma</a></span><span class="op">(</span><span class="va">pso_net</span>, </span>
<span>                  trt_effects <span class="op">=</span> <span class="st">"random"</span>,</span>
<span>                  link <span class="op">=</span> <span class="st">"probit"</span>,</span>
<span>                  prior_intercept <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">100</span><span class="op">)</span>,</span>
<span>                  prior_trt <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">10</span><span class="op">)</span>,</span>
<span>                  prior_aux <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">flat</a></span><span class="op">(</span><span class="op">)</span>,</span>
<span>                  prior_het <span class="op">=</span> <span class="fu"><a href="../reference/priors.html">half_normal</a></span><span class="op">(</span>scale <span class="op">=</span> <span class="fl">2.5</span><span class="op">)</span>,</span>
<span>                  adapt_delta <span class="op">=</span> <span class="fl">0.99</span><span class="op">)</span></span></code></pre></div>
<pre><code><span><span class="co">#&gt; Note: Setting "Supportive care" as the network reference treatment.</span></span></code></pre>
<p>Basic parameter summaries are given by the <code><a href="https://rdrr.io/r/base/print.html" class="external-link">print()</a></code>
method:</p>
<div class="sourceCode" id="cb16"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pso_fit_RE</span></span>
<span><span class="co">#&gt; A random effects NMA with a ordered likelihood (probit link).</span></span>
<span><span class="co">#&gt; Inference for Stan model: ordered_multinomial.</span></span>
<span><span class="co">#&gt; 4 chains, each with iter=5000; warmup=2500; thin=1; </span></span>
<span><span class="co">#&gt; post-warmup draws per chain=2500, total post-warmup draws=10000.</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;                         mean se_mean   sd     2.5%      25%      50%      75%    97.5% n_eff</span></span>
<span><span class="co">#&gt; d[Ciclosporin]          2.04    0.01 0.44     1.28     1.74     1.99     2.29     3.00  2717</span></span>
<span><span class="co">#&gt; d[Efalizumab]           1.19    0.00 0.18     0.81     1.11     1.19     1.27     1.56  5020</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]     1.53    0.00 0.23     1.06     1.40     1.52     1.65     2.01  5016</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]     1.93    0.00 0.27     1.34     1.79     1.92     2.06     2.49  5135</span></span>
<span><span class="co">#&gt; d[Fumaderm]             1.48    0.01 0.61     0.34     1.08     1.46     1.87     2.73  6855</span></span>
<span><span class="co">#&gt; d[Infliximab]           2.32    0.00 0.38     1.56     2.09     2.32     2.55     3.06  7156</span></span>
<span><span class="co">#&gt; d[Methotrexate]         1.72    0.01 0.65     0.55     1.31     1.70     2.10     3.09  3912</span></span>
<span><span class="co">#&gt; lp__                -3410.84    0.19 6.80 -3424.69 -3415.46 -3410.57 -3405.96 -3398.62  1306</span></span>
<span><span class="co">#&gt; tau                     0.30    0.01 0.22     0.02     0.15     0.26     0.41     0.83   932</span></span>
<span><span class="co">#&gt; cc[PASI50]              0.00     NaN 0.00     0.00     0.00     0.00     0.00     0.00   NaN</span></span>
<span><span class="co">#&gt; cc[PASI75]              0.76    0.00 0.03     0.70     0.74     0.76     0.78     0.82 16361</span></span>
<span><span class="co">#&gt; cc[PASI90]              1.56    0.00 0.05     1.46     1.53     1.56     1.60     1.67 19302</span></span>
<span><span class="co">#&gt;                     Rhat</span></span>
<span><span class="co">#&gt; d[Ciclosporin]      1.00</span></span>
<span><span class="co">#&gt; d[Efalizumab]       1.00</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg] 1.00</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg] 1.00</span></span>
<span><span class="co">#&gt; d[Fumaderm]         1.00</span></span>
<span><span class="co">#&gt; d[Infliximab]       1.00</span></span>
<span><span class="co">#&gt; d[Methotrexate]     1.00</span></span>
<span><span class="co">#&gt; lp__                1.00</span></span>
<span><span class="co">#&gt; tau                 1.01</span></span>
<span><span class="co">#&gt; cc[PASI50]           NaN</span></span>
<span><span class="co">#&gt; cc[PASI75]          1.00</span></span>
<span><span class="co">#&gt; cc[PASI90]          1.00</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; Samples were drawn using NUTS(diag_e) at Wed Aug 30 11:00:59 2023.</span></span>
<span><span class="co">#&gt; For each parameter, n_eff is a crude measure of effective sample size,</span></span>
<span><span class="co">#&gt; and Rhat is the potential scale reduction factor on split chains (at </span></span>
<span><span class="co">#&gt; convergence, Rhat=1).</span></span></code></pre></div>
<p>By default, summaries of the study-specific intercepts <span class="math inline">\(\mu_j\)</span> and study-specific relative effects
<span class="math inline">\(\delta_{jk}\)</span> are hidden, but could
be examined by changing the <code>pars</code> argument:</p>
<div class="sourceCode" id="cb17"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Not run</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/base/print.html" class="external-link">print</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, pars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"d"</span>, <span class="st">"cc"</span>, <span class="st">"mu"</span>, <span class="st">"delta"</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<p>The prior and posterior distributions can be compared visually using
the <code><a href="../reference/plot_prior_posterior.html">plot_prior_posterior()</a></code> function:</p>
<div class="sourceCode" id="cb18"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/plot_prior_posterior.html">plot_prior_posterior</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, prior <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"trt"</span>, <span class="st">"aux"</span>, <span class="st">"het"</span><span class="op">)</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_RE_pp_plot-1.png" width="700" style="display: block; margin: auto;"></p>
</div>
<div class="section level3">
<h3 id="model-comparison">Model comparison<a class="anchor" aria-label="anchor" href="#model-comparison"></a>
</h3>
<p>Model fit can be checked using the <code><a href="../reference/dic.html">dic()</a></code> function:</p>
<div class="sourceCode" id="cb19"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">dic_FE</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/dic.html">dic</a></span><span class="op">(</span><span class="va">pso_fit_FE</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Residual deviance: 74.8<span style="color: #555555;"> (on 58 data points)</span></span></span>
<span><span class="co">#&gt;                pD: 25.4</span></span>
<span><span class="co">#&gt;               DIC: 100.1</span></span></code></pre></div>
<div class="sourceCode" id="cb20"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">dic_RE</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/dic.html">dic</a></span><span class="op">(</span><span class="va">pso_fit_RE</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt; Residual deviance: 63.1<span style="color: #555555;"> (on 58 data points)</span></span></span>
<span><span class="co">#&gt;                pD: 33.4</span></span>
<span><span class="co">#&gt;               DIC: 96.6</span></span></code></pre></div>
<p>The random effects model has a lower DIC and the residual deviance is
closer to the number of data points, so is preferred in this case.</p>
<p>We can also examine the residual deviance contributions with the
corresponding <code><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot()</a></code> method.</p>
<div class="sourceCode" id="cb21"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">dic_FE</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_FE_resdev_plot-1.png" width="700" style="display: block; margin: auto;"></p>
<div class="sourceCode" id="cb22"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">dic_RE</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_RE_resdev_plot-1.png" width="700" style="display: block; margin: auto;"></p>
<p>Most data points are fit well, with posterior mean residual deviances
close to the degrees of freedom. The Meffert 1997 study has a
substantially higher residual deviance contribution, which could be
investigated further to see why this study appears to be an outlier.</p>
</div>
</div>
<div class="section level2">
<h2 id="further-results">Further results<a class="anchor" aria-label="anchor" href="#further-results"></a>
</h2>
<div class="section level3">
<h3 id="predicted-probabilities-of-response">Predicted probabilities of response<a class="anchor" aria-label="anchor" href="#predicted-probabilities-of-response"></a>
</h3>
<p><span class="citation">Dias et al. (<a href="#ref-TSD2" role="doc-biblioref">2011</a>)</span> produce absolute predictions of
probability of achieving responses at each PASI cutoff, assuming a
Normal distribution for the baseline probit probability of PASI50
response on supportive care with mean <span class="math inline">\(-1.097\)</span> and precision <span class="math inline">\(123\)</span>. We can replicate these results using
the <code><a href="https://rdrr.io/r/stats/predict.html" class="external-link">predict()</a></code> method. The <code>baseline</code> argument
takes a <code><a href="../reference/distr.html">distr()</a></code> distribution object, with which we specify
the corresponding Normal distribution. We set
<code>type = "response"</code> to produce predicted probabilities
(<code>type = "link"</code> would produce predicted probit
probabilities).</p>
<div class="sourceCode" id="cb23"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pred_FE</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/predict.html" class="external-link">predict</a></span><span class="op">(</span><span class="va">pso_fit_FE</span>, </span>
<span>                   baseline <span class="op">=</span> <span class="fu"><a href="../reference/distr.html">distr</a></span><span class="op">(</span><span class="va">qnorm</span>, mean <span class="op">=</span> <span class="op">-</span><span class="fl">1.097</span>, sd <span class="op">=</span> <span class="fl">123</span><span class="op">^</span><span class="op">-</span><span class="fl">0.5</span><span class="op">)</span>, </span>
<span>                   type <span class="op">=</span> <span class="st">"response"</span><span class="op">)</span></span>
<span><span class="va">pred_FE</span></span>
<span><span class="co">#&gt;                                mean   sd 2.5%  25%  50%  75% 97.5% Bulk_ESS Tail_ESS Rhat</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI50]  0.14 0.02 0.10 0.12 0.14 0.15  0.18     3631     3432    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI75]  0.03 0.01 0.02 0.03 0.03 0.04  0.05     3789     3232    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI90]  0.00 0.00 0.00 0.00 0.00 0.00  0.01     4246     3776    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI50]      0.78 0.10 0.57 0.72 0.79 0.85  0.94     1707     1890    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI75]      0.52 0.13 0.28 0.43 0.52 0.62  0.80     1721     1983    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI90]      0.24 0.11 0.08 0.16 0.22 0.31  0.50     1721     1992    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI50]       0.54 0.04 0.46 0.51 0.54 0.56  0.62     3152     3231    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI75]       0.25 0.04 0.19 0.23 0.25 0.28  0.33     3313     3733    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI90]       0.07 0.02 0.04 0.06 0.07 0.08  0.11     3565     3866    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI50] 0.66 0.05 0.56 0.63 0.66 0.69  0.75     2562     3057    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI75] 0.37 0.05 0.27 0.33 0.37 0.40  0.47     2665     2973    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI90] 0.13 0.03 0.08 0.11 0.13 0.14  0.19     2829     2993    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI50] 0.79 0.04 0.71 0.77 0.80 0.82  0.86     2556     2742    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI75] 0.53 0.05 0.42 0.49 0.53 0.56  0.63     2697     2753    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI90] 0.23 0.04 0.16 0.20 0.23 0.26  0.32     2852     2966    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI50]         0.64 0.16 0.31 0.53 0.64 0.76  0.93     2721     2454    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI75]         0.37 0.17 0.10 0.24 0.35 0.48  0.76     2739     2467    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI90]         0.15 0.12 0.02 0.07 0.12 0.20  0.45     2705     2500    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI50]       0.88 0.05 0.76 0.85 0.89 0.92  0.96     2671     2514    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI75]       0.68 0.10 0.48 0.61 0.68 0.75  0.85     2662     2568    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI90]       0.37 0.10 0.19 0.30 0.37 0.44  0.59     2692     2683    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI50]     0.68 0.15 0.36 0.58 0.69 0.79  0.92     2001     2264    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI75]     0.41 0.16 0.13 0.29 0.40 0.52  0.76     2007     2264    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI90]     0.17 0.11 0.03 0.09 0.14 0.23  0.45     2003     2292    1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pred_FE</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_pred_FE-1.png" width="700" style="display: block; margin: auto;"></p>
<div class="sourceCode" id="cb24"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pred_RE</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/predict.html" class="external-link">predict</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, </span>
<span>                   baseline <span class="op">=</span> <span class="fu"><a href="../reference/distr.html">distr</a></span><span class="op">(</span><span class="va">qnorm</span>, mean <span class="op">=</span> <span class="op">-</span><span class="fl">1.097</span>, sd <span class="op">=</span> <span class="fl">123</span><span class="op">^</span><span class="op">-</span><span class="fl">0.5</span><span class="op">)</span>, </span>
<span>                   type <span class="op">=</span> <span class="st">"response"</span><span class="op">)</span></span>
<span><span class="va">pred_RE</span></span>
<span><span class="co">#&gt;                                mean   sd 2.5%  25%  50%  75% 97.5% Bulk_ESS Tail_ESS Rhat</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI50]  0.14 0.02 0.10 0.12 0.14 0.15  0.18     9886     9993    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI75]  0.03 0.01 0.02 0.03 0.03 0.04  0.05    10478    10203    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI90]  0.00 0.00 0.00 0.00 0.00 0.00  0.01    11429     9859    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI50]      0.80 0.11 0.57 0.74 0.82 0.89  0.97     3358     2722    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI75]      0.56 0.16 0.28 0.45 0.56 0.67  0.87     3362     2728    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI90]      0.28 0.14 0.08 0.18 0.25 0.36  0.63     3363     2722    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI50]       0.54 0.08 0.38 0.49 0.54 0.58  0.69     5752     4812    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI75]       0.26 0.06 0.14 0.22 0.25 0.29  0.40     5869     4726    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI90]       0.07 0.03 0.03 0.06 0.07 0.09  0.15     5994     4979    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI50] 0.66 0.09 0.48 0.61 0.67 0.72  0.83     5738     4407    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI75] 0.38 0.09 0.21 0.32 0.37 0.43  0.58     5787     4541    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI90] 0.14 0.06 0.05 0.10 0.13 0.16  0.27     5868     4792    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI50] 0.79 0.08 0.59 0.75 0.80 0.84  0.92     5779     4609    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI75] 0.53 0.11 0.30 0.47 0.53 0.59  0.75     5790     4548    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI90] 0.24 0.09 0.09 0.19 0.23 0.28  0.44     5816     4549    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI50]         0.63 0.20 0.22 0.49 0.64 0.78  0.95     7087     5940    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI75]         0.37 0.20 0.06 0.22 0.35 0.51  0.81     7075     5952    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI90]         0.16 0.14 0.01 0.06 0.11 0.22  0.54     7082     5962    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI50]       0.87 0.08 0.67 0.84 0.89 0.93  0.98     7492     6191    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI75]       0.67 0.13 0.38 0.59 0.68 0.76  0.89     7499     6050    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI90]       0.37 0.14 0.13 0.28 0.36 0.46  0.67     7510     6112    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI50]     0.70 0.18 0.29 0.58 0.72 0.84  0.98     4442     3866    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI75]     0.45 0.21 0.09 0.29 0.44 0.60  0.89     4430     3914    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI90]     0.21 0.17 0.02 0.09 0.17 0.29  0.67     4434     3710    1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pred_RE</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_pred_RE-1.png" width="700" style="display: block; margin: auto;"></p>
<p>If instead of information on the baseline PASI 50 response probit
probability we have PASI 50 event counts, we can use these to construct
a Beta distribution for the baseline probability of PASI 50 response.
For example, if 56 out of 408 individuals achieved PASI 50 response on
supportive care in the target population of interest, the appropriate
Beta distribution for the response probability would be <span class="math inline">\(\textrm{Beta}(56, 408-56)\)</span>. We can specify
this Beta distribution for the baseline response using the
<code>baseline_type = "reponse"</code> argument (the default is
<code>"link"</code>, used above for the baseline probit
probability).</p>
<div class="sourceCode" id="cb25"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pred_FE_beta</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/predict.html" class="external-link">predict</a></span><span class="op">(</span><span class="va">pso_fit_FE</span>, </span>
<span>                        baseline <span class="op">=</span> <span class="fu"><a href="../reference/distr.html">distr</a></span><span class="op">(</span><span class="va">qbeta</span>, <span class="fl">56</span>, <span class="fl">408</span><span class="op">-</span><span class="fl">56</span><span class="op">)</span>,</span>
<span>                        baseline_type <span class="op">=</span> <span class="st">"response"</span>,</span>
<span>                        type <span class="op">=</span> <span class="st">"response"</span><span class="op">)</span></span>
<span><span class="va">pred_FE_beta</span></span>
<span><span class="co">#&gt;                                mean   sd 2.5%  25%  50%  75% 97.5% Bulk_ESS Tail_ESS Rhat</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI50]  0.14 0.02 0.10 0.12 0.14 0.15  0.17     3940     4002    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI75]  0.03 0.01 0.02 0.03 0.03 0.04  0.05     4192     4134    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI90]  0.00 0.00 0.00 0.00 0.00 0.00  0.01     4512     3920    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI50]      0.78 0.10 0.57 0.72 0.79 0.85  0.94     1695     2060    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI75]      0.52 0.13 0.28 0.43 0.52 0.62  0.79     1712     2023    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI90]      0.24 0.11 0.08 0.16 0.22 0.31  0.50     1703     2084    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI50]       0.54 0.04 0.46 0.51 0.54 0.56  0.61     3296     3831    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI75]       0.25 0.03 0.19 0.23 0.25 0.28  0.32     3470     4016    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI90]       0.07 0.02 0.05 0.06 0.07 0.08  0.10     3717     3772    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI50] 0.66 0.04 0.57 0.63 0.66 0.69  0.75     2975     3241    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI75] 0.37 0.05 0.28 0.34 0.37 0.40  0.46     3157     3445    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI90] 0.13 0.03 0.08 0.11 0.13 0.14  0.19     3214     3665    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI50] 0.79 0.04 0.72 0.77 0.80 0.82  0.86     2713     3184    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI75] 0.53 0.05 0.43 0.49 0.53 0.56  0.63     2961     3599    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI90] 0.23 0.04 0.16 0.20 0.23 0.26  0.31     3067     3553    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI50]         0.64 0.16 0.31 0.52 0.64 0.76  0.93     2796     2365    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI75]         0.37 0.17 0.11 0.24 0.35 0.48  0.75     2810     2452    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI90]         0.15 0.11 0.02 0.07 0.12 0.19  0.45     2764     2423    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI50]       0.88 0.05 0.76 0.85 0.89 0.92  0.96     2794     2668    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI75]       0.68 0.10 0.48 0.61 0.68 0.75  0.85     2779     2647    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI90]       0.37 0.10 0.20 0.30 0.37 0.44  0.59     2791     2648    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI50]     0.68 0.15 0.36 0.58 0.69 0.79  0.93     1980     2457    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI75]     0.41 0.16 0.13 0.29 0.40 0.52  0.76     1990     2294    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI90]     0.17 0.11 0.03 0.09 0.14 0.23  0.46     1980     2306    1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pred_FE_beta</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_pred_FE_beta-1.png" width="700" style="display: block; margin: auto;"></p>
<div class="sourceCode" id="cb26"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">pred_RE_beta</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/stats/predict.html" class="external-link">predict</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, </span>
<span>                        baseline <span class="op">=</span> <span class="fu"><a href="../reference/distr.html">distr</a></span><span class="op">(</span><span class="va">qbeta</span>, <span class="fl">56</span>, <span class="fl">408</span><span class="op">-</span><span class="fl">56</span><span class="op">)</span>,</span>
<span>                        baseline_type <span class="op">=</span> <span class="st">"response"</span>,</span>
<span>                        type <span class="op">=</span> <span class="st">"response"</span><span class="op">)</span></span>
<span><span class="va">pred_RE_beta</span></span>
<span><span class="co">#&gt;                                mean   sd 2.5%  25%  50%  75% 97.5% Bulk_ESS Tail_ESS Rhat</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI50]  0.14 0.02 0.11 0.13 0.14 0.15  0.17     9843     9606    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI75]  0.03 0.01 0.02 0.03 0.03 0.04  0.05    10708     9495    1</span></span>
<span><span class="co">#&gt; pred[Supportive care, PASI90]  0.00 0.00 0.00 0.00 0.00 0.00  0.01    11922     9653    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI50]      0.80 0.11 0.57 0.74 0.82 0.88  0.97     3308     2748    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI75]      0.56 0.15 0.28 0.45 0.56 0.67  0.88     3321     2697    1</span></span>
<span><span class="co">#&gt; pred[Ciclosporin, PASI90]      0.28 0.14 0.08 0.18 0.25 0.36  0.64     3312     2733    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI50]       0.54 0.07 0.38 0.50 0.54 0.58  0.69     6090     4709    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI75]       0.26 0.06 0.14 0.22 0.25 0.29  0.40     6255     4548    1</span></span>
<span><span class="co">#&gt; pred[Efalizumab, PASI90]       0.07 0.03 0.03 0.06 0.07 0.09  0.14     6451     4860    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI50] 0.66 0.09 0.48 0.61 0.67 0.72  0.83     5726     4571    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI75] 0.38 0.09 0.21 0.32 0.37 0.43  0.57     5787     4746    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 25 mg, PASI90] 0.14 0.06 0.05 0.10 0.13 0.16  0.27     5881     4625    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI50] 0.79 0.08 0.59 0.75 0.80 0.84  0.92     5680     4343    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI75] 0.53 0.10 0.30 0.47 0.53 0.59  0.75     5693     4284    1</span></span>
<span><span class="co">#&gt; pred[Etanercept 50 mg, PASI90] 0.24 0.09 0.09 0.19 0.23 0.28  0.45     5736     4212    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI50]         0.63 0.20 0.22 0.49 0.64 0.78  0.95     7115     5685    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI75]         0.37 0.20 0.06 0.22 0.35 0.50  0.81     7110     5892    1</span></span>
<span><span class="co">#&gt; pred[Fumaderm, PASI90]         0.16 0.14 0.01 0.06 0.11 0.21  0.53     7121     5758    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI50]       0.87 0.08 0.68 0.84 0.89 0.93  0.98     7535     6008    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI75]       0.67 0.13 0.38 0.59 0.68 0.76  0.89     7549     6255    1</span></span>
<span><span class="co">#&gt; pred[Infliximab, PASI90]       0.37 0.14 0.13 0.28 0.36 0.46  0.66     7583     6152    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI50]     0.70 0.18 0.29 0.58 0.73 0.84  0.98     4370     3753    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI75]     0.45 0.21 0.09 0.29 0.44 0.60  0.89     4369     3774    1</span></span>
<span><span class="co">#&gt; pred[Methotrexate, PASI90]     0.21 0.17 0.02 0.09 0.17 0.29  0.67     4368     3769    1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pred_RE_beta</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_pred_RE_beta-1.png" width="700" style="display: block; margin: auto;">
(Notice that these results are equivalent to those calculated above
using the Normal distribution for the baseline probit probability, since
these event counts correspond to the same probit probability.)</p>
<p>We can modify the plots using standard <code>ggplot2</code>
functions. For example, to plot the cutpoints together with a colour
coding (instead of split into facets):</p>
<div class="sourceCode" id="cb27"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://ggplot2.tidyverse.org" class="external-link">ggplot2</a></span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pred_RE</span>, position <span class="op">=</span> <span class="fu"><a href="https://ggplot2.tidyverse.org/reference/position_dodge.html" class="external-link">position_dodge</a></span><span class="op">(</span>width <span class="op">=</span> <span class="fl">0.75</span><span class="op">)</span><span class="op">)</span> <span class="op">+</span></span>
<span>  <span class="fu"><a href="https://ggplot2.tidyverse.org/reference/facet_null.html" class="external-link">facet_null</a></span><span class="op">(</span><span class="op">)</span> <span class="op">+</span></span>
<span>  <span class="fu"><a href="https://ggplot2.tidyverse.org/reference/aes.html" class="external-link">aes</a></span><span class="op">(</span>colour <span class="op">=</span> <span class="va">Category</span><span class="op">)</span> <span class="op">+</span></span>
<span>  <span class="fu"><a href="https://ggplot2.tidyverse.org/reference/scale_brewer.html" class="external-link">scale_colour_brewer</a></span><span class="op">(</span>palette <span class="op">=</span> <span class="st">"Blues"</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/pso_pred_RE_colour-1.png" width="700" style="display: block; margin: auto;"></p>
<p>If the <code>baseline</code> argument is omitted, predicted
probabilities will be produced for every study in the network based on
their estimated baseline probit probability <span class="math inline">\(\mu_j\)</span>.</p>
</div>
<div class="section level3">
<h3 id="ranks-and-rank-probabilities">Ranks and rank probabilities<a class="anchor" aria-label="anchor" href="#ranks-and-rank-probabilities"></a>
</h3>
<p>Treatment rankings, rank probabilities, and cumulative rank
probabilities can also be produced. We set
<code>lower_better = FALSE</code> since higher outcome categories are
better (the outcomes are positive).</p>
<div class="sourceCode" id="cb28"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">pso_ranks</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/posterior_ranks.html">posterior_ranks</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, lower_better <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                        mean   sd 2.5% 25% 50% 75% 97.5% Bulk_ESS Tail_ESS Rhat</span></span>
<span><span class="co">#&gt; rank[Supportive care]  7.99 0.11    8   8   8   8     8     5526       NA    1</span></span>
<span><span class="co">#&gt; rank[Ciclosporin]      2.76 1.27    1   2   3   4     5     6613     6428    1</span></span>
<span><span class="co">#&gt; rank[Efalizumab]       6.34 0.81    4   6   7   7     7     5629       NA    1</span></span>
<span><span class="co">#&gt; rank[Etanercept 25 mg] 4.92 1.06    3   4   5   6     7     6871     5862    1</span></span>
<span><span class="co">#&gt; rank[Etanercept 50 mg] 3.05 1.21    1   2   3   4     5     5194     5158    1</span></span>
<span><span class="co">#&gt; rank[Fumaderm]         4.92 1.95    1   3   5   7     7     6876     6057    1</span></span>
<span><span class="co">#&gt; rank[Infliximab]       1.81 1.18    1   1   1   2     5     3839     4463    1</span></span>
<span><span class="co">#&gt; rank[Methotrexate]     4.21 1.89    1   3   4   6     7     5652     5599    1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pso_ranks</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/hta_psoriasis_ranks-1.png" width="700" style="display: block; margin: auto;"></p>
<div class="sourceCode" id="cb29"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">pso_rankprobs</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/posterior_ranks.html">posterior_rank_probs</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, lower_better <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                     p_rank[1] p_rank[2] p_rank[3] p_rank[4] p_rank[5] p_rank[6] p_rank[7]</span></span>
<span><span class="co">#&gt; d[Supportive care]       0.00      0.00      0.00      0.00      0.00      0.00      0.01</span></span>
<span><span class="co">#&gt; d[Ciclosporin]           0.18      0.28      0.28      0.17      0.08      0.02      0.00</span></span>
<span><span class="co">#&gt; d[Efalizumab]            0.00      0.00      0.00      0.02      0.10      0.36      0.51</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]      0.00      0.01      0.09      0.21      0.39      0.26      0.04</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]      0.07      0.30      0.26      0.25      0.09      0.02      0.01</span></span>
<span><span class="co">#&gt; d[Fumaderm]              0.07      0.09      0.09      0.11      0.16      0.19      0.27</span></span>
<span><span class="co">#&gt; d[Infliximab]            0.58      0.19      0.13      0.06      0.03      0.01      0.00</span></span>
<span><span class="co">#&gt; d[Methotrexate]          0.10      0.12      0.15      0.18      0.16      0.14      0.15</span></span>
<span><span class="co">#&gt;                     p_rank[8]</span></span>
<span><span class="co">#&gt; d[Supportive care]       0.99</span></span>
<span><span class="co">#&gt; d[Ciclosporin]           0.00</span></span>
<span><span class="co">#&gt; d[Efalizumab]            0.00</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]      0.00</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]      0.00</span></span>
<span><span class="co">#&gt; d[Fumaderm]              0.01</span></span>
<span><span class="co">#&gt; d[Infliximab]            0.00</span></span>
<span><span class="co">#&gt; d[Methotrexate]          0.00</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pso_rankprobs</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/hta_psoriasis_rankprobs-1.png" width="700" style="display: block; margin: auto;"></p>
<div class="sourceCode" id="cb30"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="op">(</span><span class="va">pso_cumrankprobs</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/posterior_ranks.html">posterior_rank_probs</a></span><span class="op">(</span><span class="va">pso_fit_RE</span>, lower_better <span class="op">=</span> <span class="cn">FALSE</span>, cumulative <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                     p_rank[1] p_rank[2] p_rank[3] p_rank[4] p_rank[5] p_rank[6] p_rank[7]</span></span>
<span><span class="co">#&gt; d[Supportive care]       0.00      0.00      0.00      0.00      0.00      0.00      0.01</span></span>
<span><span class="co">#&gt; d[Ciclosporin]           0.18      0.46      0.73      0.90      0.98      1.00      1.00</span></span>
<span><span class="co">#&gt; d[Efalizumab]            0.00      0.00      0.01      0.03      0.13      0.49      1.00</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]      0.00      0.01      0.10      0.31      0.70      0.96      1.00</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]      0.07      0.38      0.64      0.89      0.98      0.99      1.00</span></span>
<span><span class="co">#&gt; d[Fumaderm]              0.07      0.16      0.25      0.37      0.53      0.72      0.99</span></span>
<span><span class="co">#&gt; d[Infliximab]            0.58      0.77      0.90      0.96      0.99      1.00      1.00</span></span>
<span><span class="co">#&gt; d[Methotrexate]          0.10      0.22      0.37      0.55      0.71      0.85      1.00</span></span>
<span><span class="co">#&gt;                     p_rank[8]</span></span>
<span><span class="co">#&gt; d[Supportive care]          1</span></span>
<span><span class="co">#&gt; d[Ciclosporin]              1</span></span>
<span><span class="co">#&gt; d[Efalizumab]               1</span></span>
<span><span class="co">#&gt; d[Etanercept 25 mg]         1</span></span>
<span><span class="co">#&gt; d[Etanercept 50 mg]         1</span></span>
<span><span class="co">#&gt; d[Fumaderm]                 1</span></span>
<span><span class="co">#&gt; d[Infliximab]               1</span></span>
<span><span class="co">#&gt; d[Methotrexate]             1</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="va">pso_cumrankprobs</span><span class="op">)</span></span></code></pre></div>
<p><img src="example_hta_psoriasis_files/figure-html/hta_psoriasis_cumrankprobs-1.png" width="700" style="display: block; margin: auto;"></p>
</div>
</div>
<div class="section level2 unnumbered">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-TSD2" class="csl-entry">
Dias, S., N. J. Welton, A. J. Sutton, and A. E. Ades. 2011.
<span>“<span>NICE DSU Technical Support Document</span> 2: A Generalised
Linear Modelling Framework for Pair-Wise and Network Meta-Analysis of
Randomised Controlled Trials.”</span> <span>National Institute for
Health and Care Excellence</span>. <a href="https://www.sheffield.ac.uk/nice-dsu" class="external-link">https://www.sheffield.ac.uk/nice-dsu</a>.
</div>
<div id="ref-Woolacott2006" class="csl-entry">
Woolacott, N., N. Hawkins, A. Mason, A. Kainth, Z. Khadjesari, Y. Bravo
Vergel, K. Misso, et al. 2006. <span>“Etanercept and Efalizumab for the
Treatment of Psoriasis: A Systematic Review.”</span> <em>Health
Technology Assessment</em> 10 (46). <a href="https://doi.org/10.3310/hta10460" class="external-link">https://doi.org/10.3310/hta10460</a>.
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p></p>
<p>Developed by David M. Phillippo.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer>
</div>

  

  <script data-goatcounter="https://multinma.goatcounter.com/count" async src="//gc.zgo.at/count.js"></script>
</body>
</html>
